View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Daratumumab 1800 / Bortezomib 1.0 / Dexamethasone 20, AL-Amyloidosis, cycle 1-2.
Protocol-ID: 2456 V1.0 (Mini), DRTM1800/BORT1.0/DEXA20, AL-Amyloidosis, C1-2Indication(s)
- Amyloidosis; ICD-10 E85.-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.09.2023